Simeglutide injection is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist and is a prefilled injection pen. Usually, there is only one unit of simethicone in a box. Simethicone is a colorless or almost colorless clear isotonic solution. It is mainly used for glycemic control in adult population with type 2 diabetes mellitus, for patients who have poor glycemic control despite treatment with metformin and/or sulfonylureas based on controlled diet and exercise. The use of this drug may reduce the risk of adverse cardiovascular events. It is recommended that diabetic patients consult the Department of Endocrinology of regular hospitals and use simethicone under the guidance of a doctor to avoid adverse consequences.